Duakem Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 28 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -26.21%
- Profit Growth -50.53%
- Ebitda -52.13%
- Net Worth 12.58%
- Total Assets 11.58%
About Duakem Pharma
Duakem Pharma Pvt Ltd (DPPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 June 1996 and has a history of 28 years and seven months. Its registered office is in Kolkata, West Bengal, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Kamlesh Khandelwal, Debal Banerjee, and Partha Karmakar serve as directors at the Company.
Company Details
-
Location
Kolkata, West Bengal, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232WB1996PTC080079
-
Company No.
080079
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
17 Jun 1996
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Duakem Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kamlesh Khandelwal
|
Director | 17-Jun-1996 | Current |
|
Debal Banerjee
|
Director | 17-Jun-1996 | Current |
|
Partha Karmakar
|
Director | 17-Jun-1996 | Current |
Financial Performance of Duakem Pharma.
Duakem Pharma Pvt Ltd, for the financial year ended 2019, experienced significant reduction in revenue, with a 26.21% decrease. The company also saw a substantial fall in profitability, with a 50.53% decrease in profit. The company's net worth Soared by an impressive increase of 12.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Duakem Pharma?
In 2019, Duakem Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Rohit Feeds Pvt LtdKamlesh Khandelwal is a mutual person
-
Plasma Infraprojects Private Limited
Kamlesh Khandelwal is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Duakem Pharma?
Unlock and access historical data on people associated with Duakem Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Duakem Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Duakem Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.